National Stock Number
6505-01-236-3942
National Stock Number (NSN) 6505-01-236-3942, or NIIN 012363942, (iopamidol injection) was assigned July 17, 1986 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.
There are 2 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Aug 27, 2015. There have been 3 contracts issued for this part number, with 3 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2DP15V1501, SPE2DP15V1058, SPE2DP15V1058, SPE2DP15V0912. The total value of the awarded contracts has been US$ 1,841.08.
There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Mar 18, 2011, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 50275. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Information is in the Hazardous Materials Information Resource System (HMIRS). NSN 6505012363942 does not contain precious metals.
This NSN is associated to Schedule B 3006300000: opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on May 01, 2024.